Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC
Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC
Recruiting · NCT07145450 · Registry updated 2026-06-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC | PDAC | Recruiting | Phase 1 / Phase 2 | 2026-06-08 | NCT07145450 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Anocca AB | 1 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Amsterdam UMC - VU Medical Center | Amsterdam | Netherlands | 1 |
| Charité Universitätsmedizin Berlin | Berlin | Germany | 15 |
| Herlev and Gentofte University Hospital | Copenhagen | Denmark | 2 |
| Karolinska University Hospital | Stockholm | Sweden | 87 |
| Ludwig-Maximilians-Universitaet Muenchen (LMU) Klinikum der Universitaet Muenchen - Campus Grosshadern - Medizinische Klinik und Poliklinik III | München | Germany | 1 |
| Radboud University Medical Center | Nijmegen | Netherlands | 40 |
| Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus | Dresden | Germany | 2 |
| Universitaetsklinikum Heidelberg | Heidelberg | Germany | 14 |
| Universitaetsklinikum Leipzig - Universitaeren Krebszentrum (UCCL) | Leipzig | Germany | 1 |
| University Hospital and Faculty of Medicine Eberhard Karls University Tübingen | Tübingen | Germany | 1 |